Anna J. Esbensen, University of Cincinnati and Cincinnati Childrens' Hospital Medical Center.
Emily K. Hoffman, Cincinnati Childrens' Hospital Medical Center.
Am J Intellect Dev Disabil. 2022 Mar 1;127(2):149-164. doi: 10.1352/1944-7558-127.2.149.
Parents of 30 school-age children with Down syndrome participated in a small-scale randomized clinical trial of a behavioral sleep treatment designed specifically for children with Down syndrome. The aim was to improve child sleep, child daytime behavior problems, caregiver sleep, and caregiver stress. The intervention spanned 5-8 weeks, and assessments occurred pre-treatment, immediately post-treatment, and three months post-treatment using a double-blinded design. Both the active treatment and a treatment-as-usual attention-controlled comparison group showed improvements in actigraphy and parent-report measures of child sleep, parent-reported child internalizing behaviors, and actigraphy measures of parent-sleep. The behavioral sleep treatment did not yield significantly different outcomes than a treatment-as-usual approach supplemented with non-sleep-specific behavioral or education sessions. Possible interpretations of study findings are discussed.
30 名学龄期唐氏综合征儿童的家长参与了一项针对唐氏综合征儿童特定设计的行为睡眠治疗的小规模随机临床试验。目的是改善儿童睡眠、儿童日间行为问题、照顾者睡眠和照顾者压力。干预措施持续 5-8 周,采用双盲设计,在治疗前、治疗后立即和治疗后三个月进行评估。主动治疗和常规治疗的注意力控制对照组在活动记录仪和父母报告的儿童睡眠、父母报告的儿童内化行为以及父母睡眠的活动记录仪测量方面都有改善。行为睡眠治疗并没有比常规治疗方法(辅以非睡眠特定的行为或教育课程)产生显著不同的结果。对研究结果的可能解释进行了讨论。